Pyroptosis and Its Role in SARS-CoV-2 Infection

Cells. 2022 May 23;11(10):1717. doi: 10.3390/cells11101717.

Abstract

The pore-forming inflammatory cell death pathway, pyroptosis, was first described in the early 1990s and its role in health and disease has been intensively studied since. The effector molecule GSDMD is cleaved by activated caspases, mainly Caspase 1 or 11 (Caspase 4/5 in humans), downstream of inflammasome formation. In this review, we describe the molecular events related to GSDMD-mediated pore formation. Furthermore, we summarize the so far elucidated ways of SARS-CoV-2 induced NLRP3 inflammasome formation leading to pyroptosis, which strongly contributes to COVID-19 pathology. We also explore the potential of NLRP3 and GSDMD inhibitors as therapeutics to counter excessive inflammation.

Keywords: NLRP3; SARS-CoV-2; gasdermins; interleukin-1β; pyroptosis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Caspases / metabolism
  • Humans
  • Inflammasomes / metabolism
  • Intracellular Signaling Peptides and Proteins / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Phosphate-Binding Proteins / metabolism
  • Pyroptosis*
  • SARS-CoV-2

Substances

  • Inflammasomes
  • Intracellular Signaling Peptides and Proteins
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Phosphate-Binding Proteins
  • Caspases

Grants and funding

This research was supported in part by the EXIST Forschungstransfer of the German Ministry for Economic Affairs and Climate Action, which is co-financed by the European Social Fund. We acknowledge support by the Open Access Publishing Fund of the University of Tübingen.